 | • レポートコード：MRC2102QY12113 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の組換えグリコシル化タンパク質市場について種類別（インスリン、rHGH、インターフェロン）、用途別（血液・腫瘍疾患、慢性疾患、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・組換えグリコシル化タンパク質市場の概要 ・世界の主要地域別組換えグリコシル化タンパク質市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の組換えグリコシル化タンパク質市場規模2015-2026：種類別（インスリン、rHGH、インターフェロン） ・世界の組換えグリコシル化タンパク質市場規模2015-2026：用途別（血液・腫瘍疾患、慢性疾患、その他） ・組換えグリコシル化タンパク質の米国市場規模2015-2020 ・組換えグリコシル化タンパク質のヨーロッパ市場規模2015-2020 ・組換えグリコシル化タンパク質の中国市場規模2015-2020 ・組換えグリコシル化タンパク質の日本市場規模2015-2020 ・組換えグリコシル化タンパク質の東南アジア市場規模2015-2020 ・組換えグリコシル化タンパク質のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・組換えグリコシル化タンパク質の製造コスト分析 ・販売チャネル、流通業者、顧客 ・組換えグリコシル化タンパク質の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Recombinant Glycosylated Protein Market
The global Recombinant Glycosylated Protein market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Recombinant Glycosylated Protein Scope and Market Size
The global Recombinant Glycosylated Protein market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant Glycosylated Protein market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Recombinant Glycosylated Protein market is segmented into
Insulin
rHGH
Interferon
Segment by Application, the Recombinant Glycosylated Protein market is segmented into
Blood & Oncology Diseases
Chronic Diseases
Others
The Recombinant Glycosylated Protein market is analysed and market size information is provided by regions (countries). Segment by Application, the Recombinant Glycosylated Protein market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Recombinant Glycosylated Protein Market Share Analysis
Recombinant Glycosylated Protein market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Recombinant Glycosylated Protein business, the date to enter into the Recombinant Glycosylated Protein market, Recombinant Glycosylated Protein product introduction, recent developments, etc.
The major vendors covered:
Novartis International AG
Hospira Inc
Celltrion Pharma Inc
Biocon Limited
Teva Pharmaceutical Industries Ltd
1 Recombinant Glycosylated Protein Market Overview
1.1 Recombinant Glycosylated Protein Product Scope
1.2 Recombinant Glycosylated Protein Segment by Type
1.2.1 Global Recombinant Glycosylated Protein Sales by Type (2020-2026)
1.2.2 Insulin
1.2.3 rHGH
1.2.4 Interferon
1.3 Recombinant Glycosylated Protein Segment by Application
1.3.1 Global Recombinant Glycosylated Protein Sales Comparison by Application (2020-2026)
1.3.2 Blood & Oncology Diseases
1.3.3 Chronic Diseases
1.3.4 Others
1.4 Recombinant Glycosylated Protein Market Estimates and Forecasts (2015-2026)
1.4.1 Global Recombinant Glycosylated Protein Sales Growth Rate (2015-2026)
1.4.2 Global Recombinant Glycosylated Protein Revenue and Growth Rate (2015-2026)
1.4.3 Global Recombinant Glycosylated Protein Price Trends (2015-2026)
2 Recombinant Glycosylated Protein Estimate and Forecast by Region
2.1 Global Recombinant Glycosylated Protein Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Recombinant Glycosylated Protein Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Recombinant Glycosylated Protein Sales Market Share by Region (2015-2020)
2.2.2 Global Recombinant Glycosylated Protein Revenue Market Share by Region (2015-2020)
2.3 Global Recombinant Glycosylated Protein Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Recombinant Glycosylated Protein Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Recombinant Glycosylated Protein Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Recombinant Glycosylated Protein Estimates and Projections (2015-2026)
2.4.2 Europe Recombinant Glycosylated Protein Estimates and Projections (2015-2026)
2.4.3 China Recombinant Glycosylated Protein Estimates and Projections (2015-2026)
2.4.4 Japan Recombinant Glycosylated Protein Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Recombinant Glycosylated Protein Estimates and Projections (2015-2026)
2.4.6 India Recombinant Glycosylated Protein Estimates and Projections (2015-2026)
3 Global Recombinant Glycosylated Protein Competition Landscape by Players
3.1 Global Top Recombinant Glycosylated Protein Players by Sales (2015-2020)
3.2 Global Top Recombinant Glycosylated Protein Players by Revenue (2015-2020)
3.3 Global Recombinant Glycosylated Protein Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Glycosylated Protein as of 2019)
3.4 Global Recombinant Glycosylated Protein Average Price by Company (2015-2020)
3.5 Manufacturers Recombinant Glycosylated Protein Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Recombinant Glycosylated Protein Players (Opinion Leaders)
4 Global Recombinant Glycosylated Protein Market Size by Type
4.1 Global Recombinant Glycosylated Protein Historic Market Review by Type (2015-2020)
4.1.1 Global Recombinant Glycosylated Protein Sales Market Share by Type (2015-2020)
4.1.2 Global Recombinant Glycosylated Protein Revenue Market Share by Type (2015-2020)
4.1.3 Global Recombinant Glycosylated Protein Price by Type (2015-2020)
4.2 Global Recombinant Glycosylated Protein Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Recombinant Glycosylated Protein Sales Forecast by Type (2021-2026)
4.2.2 Global Recombinant Glycosylated Protein Revenue Forecast by Type (2021-2026)
4.2.3 Global Recombinant Glycosylated Protein Price Forecast by Type (2021-2026)
5 Global Recombinant Glycosylated Protein Market Size by Application
5.1 Global Recombinant Glycosylated Protein Historic Market Review by Application (2015-2020)
5.1.1 Global Recombinant Glycosylated Protein Sales Market Share by Application (2015-2020)
5.1.2 Global Recombinant Glycosylated Protein Revenue Market Share by Application (2015-2020)
5.1.3 Global Recombinant Glycosylated Protein Price by Application (2015-2020)
5.2 Global Recombinant Glycosylated Protein Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Recombinant Glycosylated Protein Sales Forecast by Application (2021-2026)
5.2.2 Global Recombinant Glycosylated Protein Revenue Forecast by Application (2021-2026)
5.2.3 Global Recombinant Glycosylated Protein Price Forecast by Application (2021-2026)
6 United States Recombinant Glycosylated Protein Market Facts & Figures
6.1 United States Recombinant Glycosylated Protein Sales Market Share by Company (2015-2020)
6.2 United States Recombinant Glycosylated Protein Sales Market Share by Type (2015-2020)
6.3 United States Recombinant Glycosylated Protein Sales Market Share by Application (2015-2020)
7 Europe Recombinant Glycosylated Protein Market Facts & Figures
7.1 Europe Recombinant Glycosylated Protein Sales Market Share by Company (2015-2020)
7.2 Europe Recombinant Glycosylated Protein Sales Market Share by Type (2015-2020)
7.3 Europe Recombinant Glycosylated Protein Sales Market Share by Application (2015-2020)
8 China Recombinant Glycosylated Protein Market Facts & Figures
8.1 China Recombinant Glycosylated Protein Sales Market Share by Company (2015-2020)
8.2 China Recombinant Glycosylated Protein Sales Market Share by Type (2015-2020)
8.3 China Recombinant Glycosylated Protein Sales Market Share by Application (2015-2020)
9 Japan Recombinant Glycosylated Protein Market Facts & Figures
9.1 Japan Recombinant Glycosylated Protein Sales Market Share by Company (3015-3030)
9.2 Japan Recombinant Glycosylated Protein Sales Market Share by Type (2015-2020)
9.3 Japan Recombinant Glycosylated Protein Sales Market Share by Application (2015-2020)
10 Southeast Asia Recombinant Glycosylated Protein Market Facts & Figures
10.1 Southeast Asia Recombinant Glycosylated Protein Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Recombinant Glycosylated Protein Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Recombinant Glycosylated Protein Sales Market Share by Application (2015-2020)
11 India Recombinant Glycosylated Protein Market Facts & Figures
11.1 India Recombinant Glycosylated Protein Sales Market Share by Company (2015-2020)
11.2 India Recombinant Glycosylated Protein Sales Market Share by Type (2015-2020)
11.3 India Recombinant Glycosylated Protein Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Recombinant Glycosylated Protein Business
12.1 Novartis International AG
12.1.1 Novartis International AG Corporation Information
12.1.2 Novartis International AG Business Overview
12.1.3 Novartis International AG Recombinant Glycosylated Protein Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Novartis International AG Recombinant Glycosylated Protein Products Offered
12.1.5 Novartis International AG Recent Development
12.2 Hospira Inc
12.2.1 Hospira Inc Corporation Information
12.2.2 Hospira Inc Business Overview
12.2.3 Hospira Inc Recombinant Glycosylated Protein Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Hospira Inc Recombinant Glycosylated Protein Products Offered
12.2.5 Hospira Inc Recent Development
12.3 Celltrion Pharma Inc
12.3.1 Celltrion Pharma Inc Corporation Information
12.3.2 Celltrion Pharma Inc Business Overview
12.3.3 Celltrion Pharma Inc Recombinant Glycosylated Protein Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Celltrion Pharma Inc Recombinant Glycosylated Protein Products Offered
12.3.5 Celltrion Pharma Inc Recent Development
12.4 Biocon Limited
12.4.1 Biocon Limited Corporation Information
12.4.2 Biocon Limited Business Overview
12.4.3 Biocon Limited Recombinant Glycosylated Protein Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Biocon Limited Recombinant Glycosylated Protein Products Offered
12.4.5 Biocon Limited Recent Development
12.5 Teva Pharmaceutical Industries Ltd
12.5.1 Teva Pharmaceutical Industries Ltd Corporation Information
12.5.2 Teva Pharmaceutical Industries Ltd Business Overview
12.5.3 Teva Pharmaceutical Industries Ltd Recombinant Glycosylated Protein Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Teva Pharmaceutical Industries Ltd Recombinant Glycosylated Protein Products Offered
12.5.5 Teva Pharmaceutical Industries Ltd Recent Development
…
13 Recombinant Glycosylated Protein Manufacturing Cost Analysis
13.1 Recombinant Glycosylated Protein Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Recombinant Glycosylated Protein
13.4 Recombinant Glycosylated Protein Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Recombinant Glycosylated Protein Distributors List
14.3 Recombinant Glycosylated Protein Customers
15 Market Dynamics
15.1 Recombinant Glycosylated Protein Market Trends
15.2 Recombinant Glycosylated Protein Opportunities and Drivers
15.3 Recombinant Glycosylated Protein Market Challenges
15.4 Recombinant Glycosylated Protein Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Recombinant Glycosylated Protein Sales (K MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Recombinant Glycosylated Protein Sales (K MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Recombinant Glycosylated Protein Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Recombinant Glycosylated Protein Sales (K MT) by Region (2015-2020)
Table 5. Global Recombinant Glycosylated Protein Sales Market Share by Region (2015-2020)
Table 6. Global Recombinant Glycosylated Protein Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Recombinant Glycosylated Protein Revenue Share by Region (2015-2020)
Table 8. Global Recombinant Glycosylated Protein Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Recombinant Glycosylated Protein Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Recombinant Glycosylated Protein Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Recombinant Glycosylated Protein Revenue Share Forecast by Region (2021-2026)
Table 12. Global Recombinant Glycosylated Protein (K MT) of Key Companies (2015-2020)
Table 13. Global Recombinant Glycosylated Protein Sales Share by Company (2015-2020)
Table 14. Global Recombinant Glycosylated Protein Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Recombinant Glycosylated Protein Revenue Share by Company (2015-2020)
Table 16. Global Recombinant Glycosylated Protein by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Glycosylated Protein as of 2019)
Table 17. Global Recombinant Glycosylated Protein Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Recombinant Glycosylated Protein Manufacturing Sites and Area Served
Table 19. Manufacturers Recombinant Glycosylated Protein Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Recombinant Glycosylated Protein Players
Table 22. Global Recombinant Glycosylated Protein Sales (K MT) by Type (2015-2020)
Table 23. Global Recombinant Glycosylated Protein Sales Share by Type (2015-2020)
Table 24. Global Recombinant Glycosylated Protein Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Recombinant Glycosylated Protein Price (K MT) by Type (2015-2020)
Table 26. Global Recombinant Glycosylated Protein Sales Share by Type (2021-2026)
Table 27. Global Recombinant Glycosylated Protein Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Recombinant Glycosylated Protein Revenue Share by Type (2021-2026)
Table 29. Global Recombinant Glycosylated Protein Price (K MT) by Type (2021-2026)
Table 30. Global Recombinant Glycosylated Protein Sales (K MT) by Application (2015-2020)
Table 31. Global Recombinant Glycosylated Protein Sales Share by Application (2015-2020)
Table 32. Global Recombinant Glycosylated Protein Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Recombinant Glycosylated Protein Price (K MT) by Application (2015-2020)
Table 34. Global Recombinant Glycosylated Protein Sales (K MT) by Application (2021-2026)
Table 35. Global Recombinant Glycosylated Protein Sales Share by Application (2021-2026)
Table 36. Global Recombinant Glycosylated Protein Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Recombinant Glycosylated Protein Revenue Share by Application (2021-2026)
Table 38. Global Recombinant Glycosylated Protein Price (K MT) by Application (2021-2026)
Table 39. United States Recombinant Glycosylated Protein Sales (K MT) by Company (2015-2020)
Table 40. United States Recombinant Glycosylated Protein Sales Market Share by Company (2015-2020)
Table 41. United States Recombinant Glycosylated Protein Sales (K MT) by Type (2015-2020)
Table 42. United States Recombinant Glycosylated Protein Sales Market Share by Type (2015-2020)
Table 43. United States Recombinant Glycosylated Protein Sales (K MT) by Application (2015-2020)
Table 44. United States Recombinant Glycosylated Protein Sales Market Share by Application (2015-2020)
Table 45. Europe Recombinant Glycosylated Protein Sales (K MT) by Company (2015-2020)
Table 46. Europe Recombinant Glycosylated Protein Sales Market Share by Company (2015-2020)
Table 47. Europe Recombinant Glycosylated Protein Sales (K MT) by Type (2015-2020)
Table 48. Europe Recombinant Glycosylated Protein Sales Market Share by Type (2015-2020)
Table 49. Europe Recombinant Glycosylated Protein Sales (K MT) by Application (2015-2020)
Table 50. Europe Recombinant Glycosylated Protein Sales Market Share by Type (2015-2020)
Table 51. China Recombinant Glycosylated Protein Sales (K MT) by Company (2015-2020)
Table 52. China Recombinant Glycosylated Protein Sales Market Share by Company (2015-2020)
Table 53. China Recombinant Glycosylated Protein Sales (K MT) by Type (2015-2020)
Table 54. China Recombinant Glycosylated Protein Sales Market Share by Type (2015-2020)
Table 55. China Recombinant Glycosylated Protein Sales (K MT) by Application (2015-2020)
Table 56. China Recombinant Glycosylated Protein Sales Market Share by Application (2015-2020)
Table 57. Japan Recombinant Glycosylated Protein Sales (K MT) by Company (2015-2020)
Table 58. Japan Recombinant Glycosylated Protein Sales Market Share by Company (2015-2020)
Table 59. Japan Recombinant Glycosylated Protein Sales (K MT) by Type (2015-2020)
Table 60. Japan Recombinant Glycosylated Protein Sales Market Share by Type (2015-2020)
Table 61. Japan Recombinant Glycosylated Protein Sales (K MT) by Application (2015-2020)
Table 62. Japan Recombinant Glycosylated Protein Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Recombinant Glycosylated Protein Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Recombinant Glycosylated Protein Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Recombinant Glycosylated Protein Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Recombinant Glycosylated Protein Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Recombinant Glycosylated Protein Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Recombinant Glycosylated Protein Sales Market Share by Application (2015-2020)
Table 69. India Recombinant Glycosylated Protein Sales (K MT) by Company (2015-2020)
Table 70. India Recombinant Glycosylated Protein Sales Market Share by Company (2015-2020)
Table 71. India Recombinant Glycosylated Protein Sales (K MT) by Type (2015-2020)
Table 72. India Recombinant Glycosylated Protein Sales Market Share by Type (2015-2020)
Table 73. India Recombinant Glycosylated Protein Sales (K MT) by Application (2015-2020)
Table 74. India Recombinant Glycosylated Protein Sales Market Share by Application (2015-2020)
Table 75. Novartis International AG Corporation Information
Table 76. Novartis International AG Description and Business Overview
Table 77. Novartis International AG Recombinant Glycosylated Protein Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Novartis International AG Recombinant Glycosylated Protein Product
Table 79. Novartis International AG Recent Development
Table 80. Hospira Inc Corporation Information
Table 81. Hospira Inc Description and Business Overview
Table 82. Hospira Inc Recombinant Glycosylated Protein Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Hospira Inc Recombinant Glycosylated Protein Product
Table 84. Hospira Inc Recent Development
Table 85. Celltrion Pharma Inc Corporation Information
Table 86. Celltrion Pharma Inc Description and Business Overview
Table 87. Celltrion Pharma Inc Recombinant Glycosylated Protein Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Celltrion Pharma Inc Recombinant Glycosylated Protein Product
Table 89. Celltrion Pharma Inc Recent Development
Table 90. Biocon Limited Corporation Information
Table 91. Biocon Limited Description and Business Overview
Table 92. Biocon Limited Recombinant Glycosylated Protein Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Biocon Limited Recombinant Glycosylated Protein Product
Table 94. Biocon Limited Recent Development
Table 95. Teva Pharmaceutical Industries Ltd Corporation Information
Table 96. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 97. Teva Pharmaceutical Industries Ltd Recombinant Glycosylated Protein Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Teva Pharmaceutical Industries Ltd Recombinant Glycosylated Protein Product
Table 99. Teva Pharmaceutical Industries Ltd Recent Development
Table 100. Production Base and Market Concentration Rate of Raw Material
Table 101. Key Suppliers of Raw Materials
Table 102. Recombinant Glycosylated Protein Distributors List
Table 103. Recombinant Glycosylated Protein Customers List
Table 104. Recombinant Glycosylated Protein Market Key Trends
Table 105. Recombinant Glycosylated Protein Key Opportunities and Drivers
Table 106. Recombinant Glycosylated Protein Market Challenges
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Glycosylated Protein Product Picture
Figure 2. Global Recombinant Glycosylated Protein Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Recombinant Glycosylated Protein Market Share by Application in 2020 & 2026
Figure 6. Blood & Oncology Diseases Examples
Figure 7. Chronic Diseases Examples
Figure 8. Others Examples
Figure 9. Global Recombinant Glycosylated Protein Sales (K MT) Growth Rate (2015-2026)
Figure 10. Global Recombinant Glycosylated Protein Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Recombinant Glycosylated Protein Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 12. Global Recombinant Glycosylated Protein Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Recombinant Glycosylated Protein Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Recombinant Glycosylated Protein Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Recombinant Glycosylated Protein Sales (K MT) Growth Rate (2015-2026)
Figure 16. Europe Recombinant Glycosylated Protein Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Recombinant Glycosylated Protein Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Recombinant Glycosylated Protein Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Recombinant Glycosylated Protein Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Recombinant Glycosylated Protein Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Recombinant Glycosylated Protein Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Recombinant Glycosylated Protein Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Recombinant Glycosylated Protein Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Recombinant Glycosylated Protein Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Recombinant Glycosylated Protein Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Recombinant Glycosylated Protein Players Market Share by Revenue in Recombinant Glycosylated Protein 2015 & 2019
Figure 27. Recombinant Glycosylated Protein Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Recombinant Glycosylated Protein Revenue Share by Type (2015-2020)
Figure 29. Global Recombinant Glycosylated Protein Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Recombinant Glycosylated Protein Revenue Share by Application (2015-2020)
Figure 31. Global Recombinant Glycosylated Protein Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Recombinant Glycosylated Protein Sales Market Share by Type in 2019
Figure 33. United States Recombinant Glycosylated Protein Sales Market Share by Type in 2019
Figure 34. Europe Recombinant Glycosylated Protein Sales Market Share by Company in 2019
Figure 35. Europe Recombinant Glycosylated Protein Sales Market Share by Type in 2019
Figure 36. Europe Recombinant Glycosylated Protein Sales Market Share by Application in 2019
Figure 37. China Recombinant Glycosylated Protein Sales Market Share by Company in 2019
Figure 38. China Recombinant Glycosylated Protein Sales Market Share by Type in 2019
Figure 39. China Recombinant Glycosylated Protein Sales Market Share by Application in 2019
Figure 40. Japan Recombinant Glycosylated Protein Sales Market Share by Company in 2019
Figure 41. Japan Recombinant Glycosylated Protein Sales Market Share by Type in 2019
Figure 42. Japan Recombinant Glycosylated Protein Sales Market Share by Application in 2019
Figure 43. Southeast Asia Recombinant Glycosylated Protein Sales Market Share by Company in 2019
Figure 44. Southeast Asia Recombinant Glycosylated Protein Sales Market Share by Type in 2019
Figure 45. Southeast Asia Recombinant Glycosylated Protein Sales Market Share by Application in 2019
Figure 46. India Recombinant Glycosylated Protein Sales Market Share by Company in 2019
Figure 47. India Recombinant Glycosylated Protein Sales Market Share by Type in 2019
Figure 48. India Recombinant Glycosylated Protein Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Recombinant Glycosylated Protein
Figure 51. Manufacturing Process Analysis of Recombinant Glycosylated Protein
Figure 52. Recombinant Glycosylated Protein Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
組換え非グリコシル化タンパク質の世界市場レポート2020 Market Analysis and Insights: Global Recombinant Non-glycosylated Protein Market The global Recombinant Non-glycosylated Protein market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Recombinant Non-glycosylated Protein Scope…- 治療用組換えタンパク質の世界市場レポート2020 Recombinant Therapeutic Protein are produced by using a technique called recombinant DNA or recombinant RNA to produce proteins. The method can be divided into in vitro method and in vivo method. Both approaches are premised on the use of genetic recombination techniques to obtain recombinant vector…
- 組換えトリプシンの世界市場レポート2020 Market Analysis and Insights: Global Recombinant Trypsin Market The global Recombinant Trypsin market size is projected to reach US$ 44 million by 2026, from US$ 27 million in 2020, at a CAGR of 8.2% during 2021-2026. Global Recombinant Trypsin Scope and Market Size The global Recombinant Trypsin ma…
- 組換えヒトエンドスタチンの世界市場レポート2020 Endostatin is a naturally occurring, 20-kDa C-terminal fragment derived from type XVIII collagen. Human monomeric endostatin is a globular protein containing two disulfide bonds: Cys162−302 and Cys264−294. Market Analysis and Insights: Global Recombinant Human Endostatin Market The global Recombinan…
- 組換えヒト血清アルブミンの世界市場レポート2020 Recombinant Human Serum Albumin (Rec. HSA) is animal origin free expressed in E.coli without animal or human derived raw materials. It is also free from other contaminating serum proteins. Recombinant human serum albumin (rHSA) is genetically engineered and derived from a rice-based expression syste…